First Time Loading...

Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 5.68 HKD -0.35% Market Closed
Updated: May 5, 2024

Simcere Pharmaceutical Group Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Simcere Pharmaceutical Group Ltd
Cash from Investing Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Simcere Pharmaceutical Group Ltd
HKEX:2096
Cash from Investing Activities
¥68.3m
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Investing Activities
-¥5.9B
CAGR 3-Years
-27%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Investing Activities
-¥2.1B
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
-31%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Investing Activities
¥73.3m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Investing Activities
¥518.6m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Cash from Investing Activities
-¥93m
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Simcere Pharmaceutical Group Ltd's Cash from Investing Activities?
Cash from Investing Activities
68.3m CNY

Based on the financial report for Dec 31, 2023, Simcere Pharmaceutical Group Ltd's Cash from Investing Activities amounts to 68.3m CNY.

What is Simcere Pharmaceutical Group Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-49%

Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for Simcere Pharmaceutical Group Ltd have been -49% over the past three years .